Doctor profile · Federal record
Dr. Tamarae Dobbs, FNP-C
Nurse Practitioner · Gainesville, TX
- NPI 1720251085
- Accepts Medicare
- MIPS 82.0 / 100 · 2023
- 18 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
834 W Highway 82 Ste 102
Gainesville, TX 762402533
(940) 294-7302
fax (940) 294-7354
Credentials & registration
- NPI registered
- April 2008 — 18 yrs on file
- Profile last updated
- August 31, 2023
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Texas #693151
- Medicaid
- TX #2V0964
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720251085. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,864
Distinct HCPCS
10
Medicare allowed
$180,810
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 7,600 | 19 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 983 | 226 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 765 | 582 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 446 | 357 | $44 | |
17110 |
Destruction of skin growth, 1-14 growths | 286 | 237 | $91 | |
11102 |
Biopsy of related skin growth, first growth | 236 | 216 | $75 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 230 | 230 | $90 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 85 | 80 | $46 | |
96372 |
Injection of drug or substance under skin or into muscle | 63 | 19 | $12 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 42 | 37 | $105 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 724. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$2,321
Transactions
106
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| LEO Pharma Inc. | 9 | $381.90 | |
| Dermavant Sciences, Inc. | 16 | $372.83 | |
| Regeneron Healthcare Solutions, Inc. | 14 | $270.84 | |
| Janssen Biotech, Inc. | 12 | $269.50 | |
| GENZYME CORPORATION | 12 | $233.98 | |
| ABBVIE INC. | 15 | $184.47 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $160.81 | |
| Incyte Corporation | 4 | $82.51 | |
| Galderma Laboratories, L.P. | 2 | $68.37 | |
| Lilly USA, LLC | 3 | $63.19 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $50.21 | |
| Amgen Inc. | 3 | $40.99 | |
| Biofrontera Inc. | 2 | $37.49 | |
| UCB, Inc. | 2 | $29.82 | |
| Novartis Pharmaceuticals Corporation | 1 | $22.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
684
Patients
442
Total drug cost
$472,676
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 110 | 95 | $1,259 |
| Ketoconazole | Generic | 100 | 68 | $2,620 |
| Fluorouracil | Generic | 78 | 76 | $7,950 |
| Clobetasol Propionate | Generic | 76 | 57 | $7,183 |
| Doxycycline Hyclate | Generic | 70 | 24 | $1,309 |
| Mupirocin | Generic | 65 | 56 | $626 |
| Minoxidil | Generic | 35 | 15 | $173 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 32 | 14 | $840 |
| Methylprednisolone | Generic | 26 | 25 | $257 |
| Clindamycin Phosphate | Generic | 17 | 12 | $526 |
Frequently asked questions
What is Dr. Tamarae Dobbs's medical specialty?
Dr. Tamarae Dobbs practices Nurse Practitioner in Gainesville, TX.
Where does Dr. Tamarae Dobbs practice?
Dr. Tamarae Dobbs practices at 834 W Highway 82 Ste 102, Gainesville, TX 762402533. Office phone: 9402947302.
What is Dr. Tamarae Dobbs's NPI?
Dr. Tamarae Dobbs's National Provider Identifier (NPI) is 1720251085, issued by NPPES.
Does Dr. Tamarae Dobbs accept Medicare assignment?
Yes. Dr. Tamarae Dobbs accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tamarae Dobbs commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.